Chang et al. engineered a biomimetic dual-targeting strategy by co-loading the FAK inhibitor IN10018 and radiosensitizer bismuth (Bi) into ZIF-8 nanoparticles, followed by coating with hybrid membranes derived from cancer-associated fibroblasts (CAFs) and cancer cells. This evidence concerns the gene PTK2 and cancer.